New Strong Sell Stocks for May 29th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Corcept Therapeutics CORT is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. The Zacks Consensus Estimate for its current year earnings has been revised almost 21.4% downward over the last 60 days.

Arc Resources AETUF is engaged in the exploration, acquisition and development of oil and natural gas properties in western Canada. The Zacks Consensus Estimate for its current year earnings has been revised 20.8% downward over the last 60 days.

AG Mortgage Investment Trust MITT is a real estate investment trust which invests in, acquires and manages residential mortgage assets, other real estate-related securities and financial assets. The Zacks Consensus Estimate for its current year earnings has been revised 17.5% downward over the last 60 days.

View the entire Zacks Rank #5 List.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Source Zacks-com